MOGAS Systems & Consulting Modules Offer Safe and Reliable Solutions for Heavy Oils Refining
MOGAS Industries, Inc. (MOGAS) proudly offers the latest feat in engineering for heavy oils refining. MOGAS Systems & Consulting (MS&C) modular units (modules) are fully functional and ready for use in many process plants.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230925096331/en/
MOGAS Systems and Consulting modular unit (Photo: Business Wire)
Modules are a favorable choice compared to traditional stick-built (site fabricated) refinery units constructed on-site, which are frequently more expensive and require excessive additional construction costs due to unnecessary pipe, welding, fittings and other components. MS&C modules’ streamlined design provides many benefits to operators, including reduced capital and operations expenditures (CAPEX and OPEX).
MOGAS recently produced five high pressure letdown module units for a residue upgrade application, lowering operations risks to personnel and streamlining the unit’s processing capabilities. Modules are safer than traditional units with fewer individual components and reduce operational risks to maintenance personnel through automated programming. Featured key design options include the patented MOGAS Y-valve, which removes dead zones to ensure that process fluid cannot form coke and solidify essential components. Custom module designs can also feature purging and flushing options based on the application.
MS&C modules are available in a variety of configurations, including designs for filtration, heat exchanger, letdown and pump units. MS&C modules include both standard warranties on components and a PERFORMANCE GUARANTEE to ensure that the unit will perform as intended for a pre-determined period, providing added peace of mind to operators.
Read more about MS&C products and services on our website: https://www.mogas.com/modules
For more information, please contact MOGAS Industries at 281.449-0291 or Email: marketing@mogas.com
About MOGAS Systems & Consulting
MOGAS Systems & Consulting (MS&C), a MOGAS Industries brand, offers pre-engineered valve systems as modular units (skids) for process plants. With over five decades of MOGAS custom-engineered solutions, our proven technology and expertise have resulted in partnerships with EPCs, technology licensors and end users.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230925096331/en/
Contact information
MOGAS Industries, Inc.
Rajan Luthra, VP Sales, Marketing and Technology
rluthra@mogas.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dubai Brings Together Sport Stars and Legends, Leaders and Decision-Makers on the Largest Global Platform to Shape the Future of Sports: the World Sports Summit18.12.2025 15:40:00 EET | Press release
The Dubai Sports Council has announced the launch of the World Sports Summit (WSS), which will take place under the directives of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence and Chairman of the Executive Council of Dubai. The event is set to be held from December 29-30, 2025 at Madinat Jumeirah in Dubai, under the theme ‘Uniting the World Through Sports’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218607571/en/ Dubai Brings Together Sport Stars and Legends, Leaders and Decision-Makers on the Largest Global Platform to Shape the Future of Sports: the World Sports Summit (Photo: AETOSWire) The Summit will be the largest global gathering of its kind, bringing together a distinguished group of top sports decision-makers, experts, global stars, representatives of international sports federations and organisations, investors and innovators
Regula Wins High Customer Marks and Strong Momentum in G2’s Winter 2026 Grid Reports for Identity Verification18.12.2025 15:11:00 EET | Press release
Regula, a global developer of identity verification solutions, has been recognized by customers on G2’s review platform as one of the fastest-rising and most trusted vendors in the identity verification market. Regula is named as a Leader in three G2 Winter 2026 Grid® Reports for Identity Verification. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218134153/en/ Regula is recognized as a Leader in G2’s Winter 2026 Grid Reports for Identity Verification, reflecting strong customer satisfaction and enterprise-grade IDV capabilities. This season, Regula earned a Leader placement in G2’s Overall Grid® for Identity Verification Software, reflecting strong customer satisfaction and a growing presence in the market. The company was also named a Leader in the Momentum Grid® Report for Identity Verification, highlighting accelerating demand for Regula’s solutions and increasingly positive feedback from users. In addition, Regula a
Aptiv and Vecna Robotics to Develop Next Generation Autonomous Mobile Robots18.12.2025 15:00:00 EET | Press release
Aptiv PLC (NYSE: APTV), a global industrial technology leader, and Vecna Robotics, a pioneer in AI-driven autonomous material handling solutions, today announced a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions designed to deliver cost-efficient automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218958100/en/ Aptiv’s advanced perception portfolio and machine learning technologies will be integrated into Vecna Robotics’ platform. This partnership combines Aptiv’s industry-leading portfolio, with Vecna Robotics’ advanced autonomy and orchestration platform to provide safer, more efficient, and scalable material handling systems. “Automation is transforming the way goods move through warehouses and factories, with devices that sense, think and act in real time,” said Javed Khan, Executive Vice President, Intelligent Systems, Aptiv. “Our collaboration with Vecna Robotics
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions18.12.2025 15:00:00 EET | Press release
Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health, today announced its launch with a $165 million financing. The Series A, co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, GV (Google Ventures), QVT, and Pictet will support the advancement of Syremis’ pipeline through clinical proof of concept. Schizophrenia and other psychotic disorders remain among the most debilitating and underserved conditions worldwide, with more than 20 million people affected and facing considerable disability, elevated relapse rates, and reduced life expectancy. Despite decades of need, current treatments often fall short in both efficacy and tolerability. Syremis’ lead program, ST-905, is a dual M1/M4 muscarinic agonist under development for schizophrenia and other neuropsychiatric conditions and is currently in Phase 1. The molecule’s differentiated potency
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 13:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom